We had DNA samples at different time points and from CD8+ subfractions from four of the participants (3 MS cases and 1 control), who had somatic mutations in the STAT3 SH2 domain in our previous studies [17, 18]. The gene discussed is STAT3; the disease is myeloid sarcoma.